Christopher J. Molloy

3.8k total citations
60 papers, 2.8k citations indexed

About

Christopher J. Molloy is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Christopher J. Molloy has authored 60 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 16 papers in Oncology and 13 papers in Cell Biology. Recurrent topics in Christopher J. Molloy's work include Skin and Cellular Biology Research (8 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Cancer-related Molecular Pathways (7 papers). Christopher J. Molloy is often cited by papers focused on Skin and Cellular Biology Research (8 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Cancer-related Molecular Pathways (7 papers). Christopher J. Molloy collaborates with scholars based in United States, Germany and Australia. Christopher J. Molloy's co-authors include David S. Taylor, Timothy P. Fleming, H. Wéber, Stuart A. Aaronson, Donald P. Bottaro, Mark S. Marshall, W. Wayt Gibbs, Pier Paolo Di Fiore, S A Aaronson and Christopher E. Turner and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Christopher J. Molloy

60 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher J. Molloy United States	29	1.7k	733	386	332	278	60	2.8k
Gerhard Siemeister Germany	32	2.2k 1.3×	959 1.3×	130 0.3×	488 1.5×	150 0.5×	68	3.3k
Anders Eriksson Sweden	19	1.2k 0.7×	316 0.4×	84 0.2×	247 0.7×	259 0.9×	36	2.1k
Vanitha Ramakrishnan United States	17	784 0.5×	500 0.7×	689 1.8×	111 0.3×	289 1.0×	32	2.8k
Andreas Gschwind Germany	9	1.6k 1.0×	1.1k 1.5×	66 0.2×	202 0.6×	212 0.8×	10	2.7k
Jon Curwen United Kingdom	20	1.5k 0.9×	1.0k 1.4×	108 0.3×	107 0.3×	114 0.4×	31	2.7k
Tommy A. Brock United States	22	1.2k 0.7×	159 0.2×	603 1.6×	181 0.5×	246 0.9×	37	2.4k
Yibing Yan United States	29	2.2k 1.3×	1.9k 2.5×	114 0.3×	220 0.7×	449 1.6×	85	3.9k
Farzan Rastinejad United States	13	2.2k 1.3×	1.0k 1.4×	71 0.2×	280 0.8×	173 0.6×	13	2.9k
Samit Hirawat United States	19	1.9k 1.1×	1.3k 1.8×	137 0.4×	154 0.5×	111 0.4×	55	3.8k
Ruoxiang Wang United States	35	1.6k 1.0×	1.1k 1.5×	101 0.3×	229 0.7×	276 1.0×	86	3.2k

Countries citing papers authored by Christopher J. Molloy

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Molloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Molloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Molloy more than expected).

Fields of papers citing papers by Christopher J. Molloy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Molloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Molloy. The network helps show where Christopher J. Molloy may publish in the future.

Co-authorship network of co-authors of Christopher J. Molloy

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Molloy. A scholar is included among the top collaborators of Christopher J. Molloy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Molloy. Christopher J. Molloy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shah, Esha T., Christopher J. Molloy, Thomas Kryza, et al.. (2024). Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells. British Journal of Cancer. 130(7). 1196–1205. 8 indexed citations

Gandhi, Neha S., Esha T. Shah, Eric D. Boittier, et al.. (2021). Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy. Communications Biology. 4(1). 638–638. 14 indexed citations

Illig, Carl R., Carl L. Manthey, Sanath K. Meegalla, et al.. (2013). Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(23). 6363–6369. 3 indexed citations

Samtani, Mahesh N., et al.. (2009). Pharmacokinetic and Pharmacodynamic Modeling of Pegylated Thrombopoietin Mimetic Peptide (PEG‐TPOm) After Single Intravenous Dose Administration in Healthy Subjects. The Journal of Clinical Pharmacology. 49(3). 336–350. 27 indexed citations

Meegalla, Sanath K., Mark J. Wall, Kenneth J. Wilson, et al.. (2008). Structure-based optimization of a potent class of arylamide FMS inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(12). 3632–3637. 26 indexed citations

Subasinghe, Nalin L., Jeremy Travins, Hui Huang, et al.. (2006). A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s. Bioorganic & Medicinal Chemistry Letters. 16(8). 2200–2204. 11 indexed citations

Chaikin, Margery A., Juan Marugán, Gerald W. De Vries, et al.. (2005). A functional radioreceptor assay of alpha-V-beta-3 (αvβ3) inhibitors in plasma: Application as an ex vivo pharmacodynamic model. Journal of Biochemical and Biophysical Methods. 65(2-3). 107–120. 1 indexed citations

Das, Anuk, Don E. Griswold, Christopher J. Molloy, Andrew A. Protter, & Geoffrey J. Laurent. (2004). Fighting pulmonary fibrosis: new science brings new therapeutic opportunities. Drug Discovery Today Therapeutic Strategies. 1(3). 361–368. 5 indexed citations

Molloy, Christopher J., et al.. (1999). Novel cardiovascular actions of the activins. Journal of Endocrinology. 161(2). 179–185. 28 indexed citations

10.

Taylor, David S., et al.. (1999). Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin. Proceedings of the National Academy of Sciences. 96(4). 1633–1638. 66 indexed citations

11.

Pawlowski, John E., David S. Taylor, Maria Valentine, et al.. (1997). Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo.. Journal of Clinical Investigation. 100(3). 639–648. 50 indexed citations

12.

Valentine, Maria, Tonya Jenkins-West, H. Weber, et al.. (1995). Orally Active Endothelin Receptor Antagonist BMS-182874 Suppresses Neointimal Development in Balloon-Injured Rat Carotid Arteries. Journal of Cardiovascular Pharmacology. 26(6). 908–915. 40 indexed citations

13.

Wéber, H., David S. Taylor, & Christopher J. Molloy. (1994). Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.. Journal of Clinical Investigation. 93(2). 788–798. 132 indexed citations

14.

Cuadrado, Antonio, W. J. Issing, Timothy P. Fleming, & Christopher J. Molloy. (1994). Uneven distribution of protein kinase C‐α and ‐β isozymes in human sarcomas and carcinomas. Journal of Cellular Physiology. 159(3). 434–440. 5 indexed citations

15.

Molloy, Christopher J., David S. Taylor, & H. Wéber. (1993). Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells.. Journal of Biological Chemistry. 268(10). 7338–7345. 233 indexed citations

16.

Walker, Cheryl L., et al.. (1992). Characterization of platelet-derived growth factor and platelet-derived growth factor receptor expression in asbestos-induced rat mesothelioma.. PubMed. 52(2). 301–6. 28 indexed citations

17.

Molloy, Christopher J., Timothy P. Fleming, Donald P. Bottaro, Antonio Cuadrado, & Stuart A. Aaronson. (1992). Platelet-derived growth factor stimulation of GTPase-activating protein tyrosine phosphorylation in control and c-H-ras-expressing NIH 3T3 cells correlates with p21ras activation.. Molecular and Cellular Biology. 12(9). 3903–3909. 28 indexed citations

18.

Molloy, Christopher J. & Jeffrey D. Laskin. (1992). Altered expression of a mouse epidermal cytoskeletal protein is a sensitive marker for proliferation induced by tumor promoters. Carcinogenesis. 13(6). 963–968. 1 indexed citations

19.

Fazioli, Francesca, et al.. (1991). The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency.. Molecular and Cellular Biology. 11(4). 2040–2048. 76 indexed citations

20.

Molloy, Christopher J., Michael A. Gallo, & Jeffrey D. Laskin. (1984). Effects of the chemical irritants anthralin and benzoyl peroxide on mouse skin epithelial cell protein production. Journal of the Society of Cosmetic Chemists. 35(4). 197–205. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact